← Back to search
VIA THERAPEUTICS, LLC
AUSTIN, TX, 78750
UnclaimedClaim this profile (free)
Prime contracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | SBIR PHASE II AWARD TO VIA THERAPEUTICS | — | $1,468,122 | Sep 15, 2023 | Sep 15, 2023 – Sep 14, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI | — | $3,599,145 | Dec 19, 2022 | Aug 9, 2018 – Aug 14, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | DEVELOPMENT OF LOW-COST, SHELF-STABLE, PATIENT- ADAPTABLE CLOFAZIMINE MINI-TABLETS FOR TREATMENT OF TUBERCULOSIS IN PEDIATRICS | — | $299,995 | Nov 21, 2022 | Sep 3, 2021 – Nov 22, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.